Mid
J
JAZZAI Stock Diagnostic Report
Jazz Pharmaceuticals to acquire Actio Biosciences for $1.32B
Jazz Pharmaceuticals has agreed to acquire Actio Biosciences for $1.32 billion.
View Source Article ↗AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time